mesoblast news - 搜索图片

1920 x 1080 · jpeg
sequoiadirect.com.au
Mesoblast (ASX:MSB) wins Biotech award for Remestemcel-L - Sequoia Direct Pty Ltd
240 x 240 · jpeg
twitter.com
Quantalum (@QuantalumLLC) …
1200 x 900 · png
BioWorld
Mesoblast stock tanks on news of FDA CRL for Ryoncil BLA i…
474 x 376 · jpeg
xueqiu.com
临床研究数据获FDA认可 Mesoblast(ASX:MSB）股价 …
570 x 570 · jpeg
biotuesdays.com
Mesoblast receives FDA complete respon…

1920 x 1280 · jpeg
pharmaceutical-technology.com
Mesoblast’s remestemcel-L lowers mortality in Covid-19 ARDS patients
1280 x 367 · jpeg
mesoblast.com
Home - Mesoblast Ltd
7555 x 1080 · jpeg
mesoblast.com
2020 Annual General Meeting - Mesoblast Ltd

1920 x 1080 · jpeg
sequoiadirect.com.au
Mesoblast (ASX:MSB) receives ethics approval to treat Covid-19 patients - Sequoia Direct Pty Ltd
1200 x 675 · jpeg
americanbankingnews.com
Mesoblast Limited (NASDAQ:MESO) Receives Consensus Rating of “Hold” from Analysts - Ameri…
1200 x 551 · jpeg
bloomberg.com
Mesoblast Shares Surge 206% on Hopes for Its Covid-19 Treatment - Bloomberg

195 x 195 · jpeg
abnnewswire.net
Mesoblast Limited (ASX:MSB) Applies …
800 x 708 · jpeg
xueqiu.com
临床研究数据获FDA认可 Mesoblast(ASX:MSB）股价 …
1280 x 720 · jpeg
theaustralian.com.au
Mesoblast shares surge 9pc as FDA approval nears | The Australian
1280 x 720 · jpeg
weeklytimesnow.com.au
Mesoblast shares surge 12pc on FDA application for remestemcel-L therapy on children | The ...

1536 x 1024 · jpeg
seekingalpha.com
Mesoblast cell therapy gets FDA rare pediatric disease designati…
1920 x 1080 · jpeg
finnewsnetwork.com.au
Stocks of the Hour: Mesoblast, Andromeda Metals, Imugene | Financ…
1280 x 720 · jpeg
theaustralian.com.au
Mesoblast rallies as it submits new information to FDA for Remestemcel-L …
1280 x 720 · jpeg
weeklytimesnow.com.au
Mesoblast | US Food and Drug Administration (FDA) accepts drug dat…

1280 x 720 · jpeg
theaustralian.com.au
Mesoblast low back pain drug gets tick of approval from US FDA | The Australian
9:49
youtube.com > TheTradingChief
INVESTOR NEWS || Mesoblast has an upcoming FDA Review on Aug 2 | What you need to know.
YouTube · TheTradingChief · 254 次播放 · 2023年6月25日
375 x 211 · jpeg
smh.com.au
Mesoblast holds out hope for heart failure drug
1280 x 720 · jpeg
ntnews.com.au
ASX Health Stocks: Mesoblast crashes 54pc after FDA call | NT News

1024 x 768 · jpeg
theaustralian.com.au
Mesoblast shares surge 9pc as FDA approval nears | The Au…
1280 x 720 · jpeg
theaustralian.com.au
Mesoblast second FDA refusal, requesting more data ahead of remestemcel-L appr…
640 x 375 · jpeg
k.sina.com.cn
Mesoblast的干细胞疗法有望获批上市|干细胞|新冠肺炎_新浪新闻
1280 x 720 · jpeg
news.com.au
‘Heading down fast’: Mesoblast stock drops 11.62 per cent | news.com.au — A…

1200 x 900 · jpeg
aumanufacturing.com.au
Manufacturing news briefs - stories you might have miss…
1280 x 720 · jpeg
geelongadvertiser.com.au
Mesoblast second FDA refusal, requesting more data ahead of remestemcel-L appr…
1280 x 720 · jpeg
skynews.com.au
Medicine company Mesoblast a top performer in ASX200 and a step closer t…
1280 x 720 · jpeg
seekingalpha.com
Mesoblast Limited 2023 Q2 - Results - Earnings Call Presentation (NASDAQ:M…

1200 x 600 · jpeg
bioinformant.com
Mesoblast to Enroll 300 Patients in COVID-19 Trial of Stem Cell Therapy R…
553 x 369 · jpeg
Barron's
Mesoblast May Have an Edge on Pluristem | Barron's
2438 x 1218 · jpeg
mesoblast.com
Product Candidates Overview - Mesoblast Ltd
1280 x 720 · jpeg
theaustralian.com.au
Mesoblast shares surge on positive heart attack treatment trials | The Au…

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果